RADIOTHERAPY AND CHEMOTHERAPY FOR INOPERABLE NONSMALL CELL LUNG-CANCER

Non-small cell lung cancer is a major cause of mortality and significa nt morbidity in the UK. The majority of patients are inoperable and th e optimum management of these patients requires a multidisciplinary ap proach involving the cooperation of respiratory physicians, thoracic s urgeons and clinical oncologists (radiotherapists). Treatment techniqu es are constantly being refined and new approaches developed.